Epifenac Tablets

Composition

Inactive Ingredients: 

EPIFENAC 25 mg Enteric-coated Tablets:

Lactose monohydrate, maize starch, microcrystalline cellulose, povidone XL, magnesium stearate, colloidal silicon dioxide, sodium starch glycolate, Cellulpse acetate phathalate, quinoline yellow, castor oil, methanol, acetone.

EPIFENAC 50 mg Enteric-coatedTablets:

Lactose monohydrate, maize starch, microcrystalline cellulose, crospovidone, sodium starch glycolate, colloidal silicon dioxide, magnesium stearate, cellulose acetate phthalate, castor oil, iron oxide red, iron oxide black.

EPIFENAC 75 mg Sustained Release Film-coated Tablets:

Lactose, avicel PH 101, polyvinyl pyrollidone K 30, hydroxypropyl methylcellulose K15M, magnesium stearate, hydroxypropyl methylcellulose 2910, iron oxide red, Polyethylene glycol 4000, titanium dioxide.

EPIFENAC 100 mg Sustained Release Film-coated Tablets:

Lactose monohydrate, avicel PH 101, polyvinyl pyrollidone K 30, hydroxypropyl methylcellulose K15M, magnesium stearate, hydroxypropylmethyl cellulose 2910, FD&C red No 40 lake, Polyethylene glycol 4000, titanium dioxide.

Therapeutic Indications

Adults and Elderly:

Relief of all grades of pain and inflammation in a wide range of conditions, including:

Arthritic conditions: Osteoarthritis, ankylosing spondylitis, rheumatoid arthritis, acute gout.

Acute musculo-skeletal disorders: Periarthritis (for example frozen shoulder), tendinitis, tenosynovitis, bursitis.

Other painful conditions resulting from trauma including: fracture, low back pain, sprains, strains, dislocations, orthopaedic, dental and other minor surgery.

EPIFENAC 25 mg Tablets: 

Children (aged 1-12 years):

Juvenile chronic arthritis.

EPIFENAC 50 mg Tablets are not recommended for children.

EPIFENAC 75 mg and 100 mg SR Tablets are not suitable for children.